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Fam96a mRNA, which encodes a mammalian DUF59 protein,
is enriched in macrophages. Recombinant human Fam96a
forms stable monomers and dimers in solution. Crystal
structures of these two forms revealed that each adopts a
distinct type of domain-swapped dimer, one of which is
stabilized by zinc binding. Two hinge loops control Fam96a
domain swapping; both are flexible and highly conserved,
suggesting that domain swapping may be a common feature
of eukaryotic but not bacterial DUF59 proteins. The derived
monomer fold of Fam96a diverges from that of bacterial
DUF59 counterparts in that the C-terminal region of Fam96a
is much longer and is positioned on the opposite side of the
N-terminal core fold. The putative metal-binding site of
bacterial DUF59 proteins is not conserved in Fam96a, but
Fam96a interacts tightly in vitro with Ciao1, the cytosolic iron-
assembly protein. Moreover, Fam96a and Ciao1 can be co-
immunoprecipitated, suggesting that the interaction also
occurs in vivo. Although predicted to have a signal peptide,
it is shown that Fam96a is cytoplasmic. The data reveal that
eukaryotic DUF59 proteins share intriguing characteristics
with amyloidogenic proteins.
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Accepted 14 February 2012
PDB References: Fam96a,
major dimer, 3ux2; Fam96a,
minor dimer, 3ux3.
1. Introduction
Over 3000 protein families containing a ‘domain of unknown
function’ (DUF) have been classified in Pfam (Finn et al.,
2008). Proteins that contain the DUF59 domain exist in
prokaryotes and eukaryotes, but the majority are found in
bacteria and yeast. Several lines of evidence suggest a specific
role for metal binding in DUF59 family members. Thus, in
aerobic bacteria the two DUF59 proteins PaaD and PaaJ
are metal-binding subunits of the phenylacetyl-coenzyme A
oxygenase complex (Song et al., 2006). Another study reported
that the DUF59 domain-containing protein HCF101 is likely
to be responsible for Fe–S cluster assembly in the model plant
Arabidopsis (Lezhneva et al., 2004). Moreover, sequence and
structure analysis of the DUF59 protein TM0487 from Ther-
motoga maritima suggested a conserved metal-binding active
site and a possible role for bacterial DUF59 proteins in
binding Fe–S clusters (Macedo et al., 2002; Almeida et al.,
2005).
Fam96a (family with sequence similarity 96 member A) is
one of only two DUF59 proteins encoded in mammals. The
other is Fam96b, also known as MIP18. The two Fam96
proteins share 50% sequence identity and differ in that
Fam96a has a predicted signal sequence whereas Fam96b does
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not. Yeast two-hybrid (Y2H) data for Fam96a and Fam96b
indicated that they may both interact with the protein Ciao1
(cytosolic iron–sulfur protein assembly 1; Rual et al., 2005;
Balk et al., 2005). Recently, Fam96b and Ciao1 were shown to
form part of the MMXD complex (MIP18–MMS19–XPD)
with three other proteins [adenine nucleotide translocator 2
(ANT2), MMS19 nucleotide-excision repair protein homo-
logue (MMS19) and the XPD transcription subunit; Ito et al.,
2010]. The MMXD complex is responsible for DNA repair and
correct chromosome segregation (Ito et al., 2010; Fan et al.,
2008). Knockdown of Fam96b in the human epithelial cell
lines HCT116 and HeLa led to mis-localization of the mitotic
spindle and an accumulation of abnormally shaped nuclei (Ito
et al., 2010). An additional function of Fam96b has recently
been reported: in endothelial cells, Fam96b down-regulates
the expression of the transcription factor E2-2. Since E2-2
negatively regulates the VEGF receptor 2 promoter, over-
expression of Fam96b promotes endothelial cell migration and
proliferation (Yang et al., 2011). These data would therefore
suggest that Fam96b is a positive regulator of angiogenesis.
Macrophages are key cellular regulators of innate immunity
and also contribute to pathological processes in both acute
and chronic inflammatory diseases. As such, macrophage-
specific proteins are potentially important regulators of
inflammation and could also prove useful as targets for anti-
inflammatory design. Analysis of existing microarray data
(http://biogps.org) indicated that mRNA expression of
Fam96a was elevated in macrophages compared with other
cell types and we therefore carried out a comprehensive
structural and functional study of this protein.
Here, we confirm that Fam96a mRNA is enriched in
macrophages and present in vitro and in vivo data validating
a Fam96a–Ciao1 interaction. Crystal structure determination
unexpectedly revealed that Fam96a forms two distinct
domain-swapped dimers; there are tantalizing similarities to
amyloidogenic proteins, which also form domain-swapped
dimers.
2. Experimental procedures
2.1. Antibodies and constructs
Polyclonal anti-HA (H6908) antibody was obtained from
Sigma–Aldrich. Anti-V5 monoclonal antibody (MCA1360)
was obtained from AbD Serotec. Fam96a and Ciao1 for
mammalian expression were amplified from murine macro-
phage cDNA and cloned into pEF6/V5-HisTOP (Invitrogen)
in frame with a C-terminal C5 and His tag. A C-terminal
HA tag was subsequently incorporated into Ciao1 by PCR
amplification using the reverse primer 50-TCAAGCGTAAT-
CGCACATCGTATGGGTAGAGACCTGTGCAGGCTGG-
TG-30.
2.2. Cell culture and transfection
Cell-culture and transfection reagents were obtained from
Invitrogen. HeLa cells were maintained in Dulbecco’s Modi-
fied Eagle’s Medium (DMEM; 25 mM glucose) supplemented
with 10% foetal bovine serum, 2 mM GlutaMAX I and non-
essential amino acids and were transfected using Lipofect-
amine with Plus Reagent according to the manufacturer’s
protocols. Briefly, cells were seeded at 40–50% confluence
onto glass cover slips in a 24-well plate. After 24 h, the wells
were washed with OptiMEM reduced serum medium
containing 2 mM GlutaMAX I and the medium was replaced
with 0.5 ml of the same. A transfection mixture of 0.25 mg
DNA and 1 ml Plus Reagent in 50 ml OptiMEM (per well) was
prepared and incubated for 5 min at room temperature (RT)
before combining with a mixture of 1 ml Lipofectamine in
50 ml OptiMEM (per well). After incubation for 25 min at RT
to allow lipid-complex formation, the final mixture was added
to the prepared cells. The medium was replaced with complete
culture medium after 3 h and the cells were fixed after 8 h.
2.3. Immunofluorescence microscopy
Cells were fixed and processed for immunofluorescence
microscopy as described previously (Richards et al., 2002) with
the following exceptions: fixation in 4% paraformaldehyde
was followed by permeabilization in 0.1% Triton X-100 in
phosphate-buffered saline (PBS) and the blocking solution
was 0.5% bovine serum albumin in PBS. Experiments were
viewed and imaged using either a Zeiss Axioplan 2 epifluor-
escent microscope or a Zeiss LSM 510 META confocal
microscope and figures were prepared using ImageJ, Adobe
Photoshop CS5.1 and Adobe Illustrator CS5.1 software.
2.4. Immunoprecipitation
Cells were harvested on ice into lysis buffer (50 mM
HEPES, 150 mM NaCl, 1% Triton X-100, 1 mM Na3VO4,
30 mM NaF, 10 mM Na4P2O7, 10 mM EDTA) containing a
1:25 dilution of protease-inhibitor cocktail (Sigma–Aldrich,
catalogue No. P8340) and cleared (16 000g for 20 min at
277 K). Lysates were incubated overnight with 1 mg mono-
clonal anti-V5 before incubation for 4 h at 277 K with Protein
G Agarose beads (Pierce) which had been blocked with 0.5%
BSA in lysis buffer for 1 h at 277 K. The beads were washed
four times in lysis buffer before the addition of DTT-
containing sample buffer and boiling for 5 min. SDS–PAGE
and Western blotting were performed as described previously
(Richards et al., 2006).
2.5. Topology determination: digitonin/trypsin method
Using a method adapted from a previous paper (Wunder et
al., 2010), transfected cells were washed twice in KHM buffer
(110 mM potassium acetate, 20 mM HEPES pH 7.4, 2 mM
MgCl2) before treatment with 20 mM digitonin in KHM buffer
for 2 min at RT. Cells were then either washed once more
in KHM buffer before harvesting of lysates (‘digitonin only’
condition) or further treated with 16 mM trypsin–EDTA in
KHM buffer for 2 min at RT and then harvested (‘digitonin +
trypsin’ condition). Trypsin treatment was terminated by
addition of serum-containing medium. Lysates were cleared
and equal volumes were loaded for analysis by SDS–PAGE
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and Western blotting for the epitope tags on the transfected
proteins.
2.6. Topology determination: freeze–thaw method
Cells were seeded on glass cover slips, transfected and
allowed to express for 8–9 h prior to topology determination
by the method of Mardones & Gonza´lez (2003). Briefly, the
cover slips were washed and quick-frozen by placing them cell-
side up on a metal block pre-chilled in a 193 K freezer. After
10 s, the cover slips were transferred to another metal block
pre-heated to 313 K for a further 10 s before fixation in 4%
paraformaldehyde for 20 min at RT. The cells were subse-
quently permeabilized with 0.2% Triton X-100 in PBS for
15 min, or not permeabilized, before routine processing for
immunofluorescence microscopy.
2.7. Quantitative real-time PCR
For primary cell populations, mouse T and B cells were
purified from the spleens of C57BL/6 mice using MACS cell
separation (Miltenyi Biotec) and CD90.2 and CD19 beads,
respectively. Mouse macrophages (thioglycollate-elicited
peritoneal macrophages) were generated from C57BL/6 mice.
In brief, mice were administered (intraperitoneal injection)
1 ml sterile thioglycollate broth [10%(w/v) in H2O]. After 5 d,
elicited macrophages were harvested by peritoneal lavage. To
generate human monocyte-derived macrophages (HMDMs),
CD14+ monocytes were purified from buffy coats using MACS
CD14 positive selection kits (Miltenyi Biotec) and were
cultured in the presence of 1  104 U ml1 recombinant
human CSF-1 (Chiron) for 7 d. For all cell populations shown,
RNA was purified using the RNeasy Mini Kit (Qiagen)
following the manufacturer’s instructions. cDNA was synthe-
sized from 1.25 mg total RNA using Superscript III Reverse
Transcriptase (Invitrogen). The CT (cycle threshold) values of
housekeeping control genes (Hprt, Tbp, Cxxc1 and Rpl13a for
mouse and HPRT and TBP for human) were averaged to
obtain overall housekeeping gene CT values that were used to
normalize Fam96a mRNA expression across the different cell
populations.
2.8. Purification of Fam96a
Full-length human FAM96A was purchased from Open
Biosystems and the construct that we used (residues 31–157)
was cloned into the vector pMCSG7 (encoding an N-terminal
His tag) by ligation-independent cloning (Stols et al., 2002).
His-tagged Fam96a was expressed in Escherichia coli BL21
(DE3) pLysS at 298 K for 24 h by autoinduction (Studier,
2005). Cell pellets were lysed in 150 ml (per litre of culture)
lysis buffer consisting of 50 mM HEPES pH 7.5, 300 mM
NaCl, 5 mMMgCl2, 5% glycerol, 1% Triton X-100, 25 mg ml
1
DNase (Sigma–Aldrich) and 100 ml Protease Inhibitor Cock-
tail III (AG Scientific Inc.). Metal-affinity chromatography
was performed using TALON cobalt resin (Clontech). The
lysate was centrifuged at 20 000 rev min1 for 30 min using a
JA25.5 rotor in an Avanti J-25I centrifuge (Beckman Coulter)
to separate soluble supernatant and insoluble cell pellet.
Supernatant from the cell lysate was incubated with 4 ml resin
for 2 h at 277 K with rotation. The resin was washed with
100 ml wash buffer consisting of 50 mM HEPES pH 7.5,
300 mM NaCl, 20 mM imidazole. His-tagged Fam96a was
eluted with 50 mM HEPES pH 7.5, 300 mM NaCl, 300 mM
imidazole.
Following metal-affinity purification, 1 mg tobacco etch
virus (TEV) protease was added per 100 mg eluted protein to
remove the His tag from Fam96a. The mixture was dialyzed
for 48 h in 3500 Da molecular-weight cutoff membrane tubing
(Pacific Laboratory) against 2 l dialysis buffer consisting of
50 mM HEPES, 300 mM NaCl, 5% glycerol, 2 mM fresh DTT
at 277 K. After dialysis, cleaved and uncleaved proteins were
separated using TALON resin. The flowthrough containing
the His-tag-cleaved protein was collected and further purified
by size-exclusion chromatography (SEC). The protein was
eluted at 1 ml min1 from a Superdex 75 16/60 column
(Amersham Biosciences) equilibrated with SEC buffer
(25 mMHEPES pH 7.5, 150 mMNaCl, 2 mM fresh DTT). The
SEC column was calibrated with protein molecular-weight
standards 12 000–200 000 Da (Sigma). Protein concentrations
were measured using the Bradford assay (Bio-Rad).
To evaluate the effect of zinc on Fam96a, the purified
monomer fraction was buffer-exchanged into 25 mM sodium
acetate pH 5.0, 150 mM NaCl, 1 mM zinc acetate and incu-
bated for 6 d at 277 K. After 1 and 6 d, the oligomeric state of
the protein was analysed using a Superdex 75 16/60 column.
At 6 d Fam96a had precipitated and was collected by centri-
fugation for 10 min at 4000 rev min1. Prior to SEC analysis
using the same column the pellet was solubilized in 25 mM
HEPES pH 7.5, 150 mM NaCl.
Seleno-dl-methionine-labelled Fam96a was expressed in
minimal medium containing 100 mg seleno-dl-methionine
(SeMet) per litre of culture using E. coli BL21 (DE3) strain at
298 K by IPTG induction, similar to the method described
elsewhere (Edeling et al., 2001). The purification of SeMet-
labelled Fam96a followed the same procedure as used for the
native protein.
2.9. Purification of Ciao1
Full-length human CIAO1 was purchased from Open
Biosystems and cloned into pMCSG7 using ligation-indepen-
dent cloning (Stols et al., 2002). Full-length His-tagged Ciao1
was expressed and purified as described for Fam96a. Purified
Ciao1 was mixed with either dimeric or monomeric purified
Fam96a. To separate unbound protein, the Ciao1–Fam96a
mixtures were eluted on a Superdex 200 16/60 column
(Amersham Biosciences) equilibrated with SEC buffer, with
the major peak eluting at the volume expected for a monomer.
2.10. Site-directed mutagenesis
The mutants 85-PTVP-88-AAAA and 87-VP-88-AA were
generated using the QuikChange site-directed mutagenesis
protocol following the manufacturer’s instructions (Strata-
gene). The 123–157 deletion mutant was cloned using
primers designed to remove the C-terminal residues. The
research papers
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mutants were transformed into E. coli BL21 (DE3) pLysS and
expressed and purified following the same procedure as used
for the native protein.
2.11. Crystal structure determination of Fam96a
Initial crystals of Fam96a major dimer were grown by
hanging-drop vapour diffusion at 277 K from 1 ml protein
solution at 30 mg ml1 and 1 ml reservoir solution consisting
of 50 mM HEPES pH 7.0, 200 mM ammonium sulfate, 30%
polyethylene glycol (PEG) 3350. The best-quality crystals of
the major dimer were obtained using a streak-seeding tech-
nique with serial dilution of protein concentration (Bergfors,
2003). Crystals grown at 30 mg ml1 were used to seed the
same condition containing 13 mg ml1 protein. Initial crystals
of Fam96a minor dimer were grown by hanging-drop vapour
diffusion at 277 K from 1 ml protein solution at 33 mg ml1
and 1 ml reservoir solution consisting of 50 mM sodium acetate
pH 4.7, 0.1M sodium malonate, 5% dimethyl sulfoxide
(DMSO), 17% PEG 3350, 10 mM zinc acetate. The optimal
crystals of the minor dimer were obtained by streak-seeding
of crystals grown at 33 mg ml1 into the same condition with
15 mg ml1 protein. Minor-dimer crystals could not be gener-
ated when the zinc acetate was replaced by nickel sulfate,
iron(II) acetate or magnesium sulfate, but could be grown in
the presence of zinc sulfate.
Prior to data collection, the major dimer crystal (approx-
imate dimensions of 0.2  0.1  0.02 mm) was soaked in
cryoprotectant consisting of 50 mM HEPES pH 7.0, 200 mM
ammonium sulfate, 30% PEG 3350, 10% glycerol and then
flash-cooled in liquid nitrogen. The crystal of the minor dimer
was soaked in cryoprotectant consisting of 50 mM sodium
acetate pH 4.7, 0.1M sodium malonate, 5% DMSO, 17% PEG
3350, 10 mM zinc acetate, 15% PEG 400. X-ray diffraction
data were measured on the Australian Synchrotron MX2
beamline (ADSC Quantum 315r detector) at a temperature of
100 K and a wavelength of 0.9184 A˚ using the Blu-Ice software
(McPhillips et al., 2002). The data were indexed and integrated
by XDS (Kabsch, 2010) and scaled using SCALA (Winn et al.,
2011). Phases for the major-dimer structure were determined
by single-wavelength anomalous dispersion (SAD) methods
using data measured from a SeMet Fam96a crystal in the range
20.0–1.8 A˚; f 0 and f 00 used for phasing were 0.8787 and
1.1389, respectively. The crystal was grown in the same way as
the native crystals. Heavy-atom positions were determined by
SHELXC/D/E (Sheldrick, 2010) and phases were generated
by Phaser (McCoy et al., 2007). Initial model building was
performed using ARP/wARP (Morris et al., 2003).
The minor-dimer structure was solved using data obtained
from a crystal with approximate dimensions of 0.1  0.1 
0.15 mm. The crystal was soaked in cryoprotectant consisting
of 90 mM sodium acetate pH 4.7, 240 mM sodium malonate,
5.7% DMSO, 16% PEG 3350, 10 mM zinc acetate, 15% PEG
400. X-ray diffraction data were measured on the Australian
Synchrotron MX2 beamline (ADSC Quantum 315r detector)
at a temperature of 100 K and a wavelength of 0.9537 A˚.
Phases for the minor dimer were determined by molecular
replacement with Phaser (McCoy et al., 2007). Initially, we
attempted to solve the structure using a ‘closed’ monomer
structure modelled from the major dimer, but this did not
result in any phasing solutions. Instead, the solution was found
using an ‘open’ monomer from the major dimer with residues
58–61 deleted and allowing the two subunits to be fitted
independently.
Structure refinement was performed using PHENIX
(Adams et al., 2010). Isotropic B-factor refinement was used
and riding H atoms were included. For the minor dimer,
anisotropic B-factor refinement was performed for the Zn
atoms. Waters were added using the ordered solvent process
with default parameters in PHENIX and were checked
manually. In each round of refinement, the refined model was
rebuilt manually using Coot (Emsley & Cowtan, 2004) with
Fo  Fc difference maps as a guide. The quality and geometry
of the refined structures were evaluated byMolProbity (Chen
et al., 2010). Structure figures were made using PyMOL
(DeLano, 2002) and structure comparison was performed
using DALI (Holm & Rosenstro¨m, 2010).
Three zinc ions were observed in the minor-dimer crystal
structure. One zinc ion has a trigonal bipyramidal coordina-
tion, forming equatorial interactions with the sulfurs of two
Cys90 residues and the oxygen of a bound acetate. All three
zincs were modelled with anisotropic B factors. In both
molecules in the asymmetric unit of the minor-dimer structure
the electron density for the loop comprising residues 73–76
was relatively poor, indicating that this region is flexible.
Coordinates and structure factors have been deposited in the
PDB (3ux2 for the major dimer; 3ux3 for the minor dimer).
2.12. Chemical cross-linking
Dimeric and monomeric forms of Fam96a isolated by SEC
were concentrated to 5 mg ml1. For cross-linking, 5 ml of
10 mM bis-sulfosuccinimidyl suberate (BS3) cross-linker was
mixed with 50 ml dimer and monomer separately. Once the
BS3 cross-linker had been added, 12 ml of reaction sample was
removed immediately and 4 ml of fresh 0.5M ammonium
carbonate was added to stop the reaction (time = 0; T0). The
step was repeated after 10 min (T1) and after 1 h (T2) of
reaction. All samples were analyzed using SDS–PAGE.
2.13. Analytical ultracentrifugation
Sedimentation-equilibrium analytical ultracentrifugation
was performed for purified monomeric and dimeric forms of
Fam96a. Both samples were concentrated to 0.3 mg ml1 in
25 mM HEPES pH 7.5, 150 mM NaCl, 2 mM DTT. For each
experiment, the protein was loaded into two-channel quartz-
window sedimentation-velocity cells in an XLI analytical
ultracentrifuge (Beckman Coulter) using an SW60Ti rotor.
Sedimentation-equilibrium data were recorded at 277 K at a
speed of 18 000 rev min1 (43 700g) as well as 42 000 rev min1
(238 000g) to determine the baseline. Absorbance was moni-
tored at 240 nm. SEDNTERP software (Alliance Protein
Laboratory) was used to calculate the protein and buffer
properties and the data were analysed using SEDANAL
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(Stafford & Sherwood, 2004). The samples were run three
times.
2.14. Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were
performed at 298 K using an ITC200 (Microcal). Fam96a
and Ciao1 were purified by SEC in 25 mM HEPES pH 7.5,
150 mM NaCl, 2 mM DTT before the titrations. For thermo-
dynamic characterization of the interaction of Fam96a and
Ciao1, Fam96a monomer or dimer at 160–660 mM was injected
into a sample cell containing Ciao1 at 15–55 mM. Each
experiment involved 16 injections of 2.45 ml with a stirring
speed of 1000 rev min1 and a spacing period of 180 s between
injections. The c values are higher than optimal (>1000) owing
to limitations of the experimental setup; the binding affinity
may not be accurate as a consequence of these limitations.
Thermodynamic parameters including equilibrium constant
Ka (=1/Kd), binding enthalpy (H), Gibbs free energy (G)
and entropy change (TS) of the interactions were calculated
from the heat of binding measured using MicroCal Origin 7.0
software (OriginLab). Stoichiometry (N) was refined initially
and the value obtained was close to 1; after this, N was set to
1.0 for calculations. Thermodynamic parameters from three
independent experiments were averaged to give the standard
error of the mean (SEM).
3. Results
3.1. Fam96a mRNA is enriched in macrophages
Expression-profiling data for an extensive panel of mouse
and human cell types has enabled the rapid mapping of tissue-
specific gene-expression programmes (Su et al., 2004; Wu et al.,
2009). We previously used this approach to identify macro-
phage-enriched GPCRs (Lattin et al., 2008). These data also
showed that Fam96a mRNA was expressed at elevated levels
in mouse macrophage and related lineages compared with
other cell types. To investigate the possible role of Fam96a in
macrophages, we first confirmed that mRNA was expressed
at elevated levels in this cell type. Quantitative real-time PCR
analysis showed that Fam96a mRNA was expressed at higher
levels in mouse macrophage cell lines (RAW264 and WR19M)
compared with lymphoblast and fibroblast cell lines (Supple-
mentary Fig. S1a1). Moreover, Fam96a mRNA expression in
primary mouse macrophages was around fourfold higher than
in primary B cells and T cells (Supplementary Fig. S1b1).
Fam96a mRNA expression was similarly elevated in human
monocyte-derived macrophages compared with a panel of
human cell lines (Supplementary Fig. S1c1). Together, these
data indicate that Fam96a mRNA is enriched in macrophages
in both humans and mice, suggesting a potential role in
macrophage biology and inflammatory pathways.
3.2. Fam96a forms stable monomers and dimers in solution
Size-exclusion chromatography (SEC) of purified recom-
binant human Fam96a lacking the N-terminal signal peptide
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Figure 1
Oligomeric state of Fam96a. (a) Three distinct peaks elute from SEC of
purified recombinant human Fam96a: peak 1, oligomer; peak 2, dimer;
peak 3, monomer. The isolated monomer and dimer peaks remained
stable for one week at 277 K. (b) SDS–PAGE of the three peaks: lanes 1,
2 and 3 contain oligomer, dimer and monomer, respectively. (c)
Continuous size distributions determined by sedimentation-equilibrium
analytical ultracentrifugation of monomeric (unbroken line) and dimeric
(dashed line) Fam96a at 0.3 mg ml1. The image shown is representative
of three scans. (d) The PTVP85AAAAmutant separated into two species
on SEC consistent with oligomers and monomers. The VP87AA mutant
separated into three species on SEC; as in native Fam96a, this is
consistent with the formation of oligomers, dimers and monomers.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: CB5007). Services for accessing this material are described at the
back of the journal.
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revealed three peaks, indicating the possibility of several
oligomeric states (Figs. 1a and 1b). The first peak eluted in
or near the void volume, suggesting the formation of large
oligomers. SDS–PAGE analysis of this first peak revealed a
ladder-like pattern (Fig. 1b), and this ladder was present
whether or not 100 mM DTT reducing agent was used and
whether or not the sample was boiled at 373 K for several
minutes (not shown), suggesting that the peak comprises a
mixture of higher order oligomers. The next peak eluted at a
volume consistent with a Fam96a dimer and the third peak at
a volume consistent with a Fam96a monomer. When the dimer
and monomer peaks were separated and left for 7 d, no
subsequent equilibration into two forms occurred, suggesting
that the monomeric and dimeric forms are stable in solution
under the conditions that we used and that there is an ener-
getic barrier to conversion between the two forms (Fig. 1a).
Analytical ultracentrifugation data showed that the purified
monomer peak equilibrates at 15 kDa (consistent with a
monomer) and the purified dimer peak
equilibrates at 30 kDa (consistent
with a dimer) (Fig. 1c). Chemical cross-
linking with bis-sulfosuccinimidyl sube-
rate (BS3) provides further support for
the second peak representing a dimer
(Supplementary Fig. S2a) and the third
peak a monomer of Fam96a (Supple-
mentary Fig. S2b). Taken together, the
SEC, ultracentrifugation and cross-
linking data suggest that Fam96a can
exist in stable monomeric and dimeric
forms in solution.
3.3. Fam96a interacts with Ciao1
Y2H data suggested that Fam96a and
Fam96b can each form a complex with
Ciao1 (Rual et al., 2005), a 38 kDa
protein responsible for iron–sulfur
cluster-protein assembly in the cyto-
plasm and nucleus (Sharma et al., 2010;
Balk et al., 2005). We analysed the
interaction between purified forms of
Fam96a and Ciao1 using isothermal
titration calorimetry. We found that
both the monomeric and dimeric forms
of Fam96a interact with full-length
Ciao1 with similar dissociation
constants in the nanomolar range
(Table 1; Supplementary Fig. S3). The
binding-affinity values for Ciao1 of the
Fam96a monomer and dimer are similar
and they interact with one and two
molecules of Ciao1, respectively.
We then examined the possibility of
an interaction between Fam96a and
Ciao1 in cells. HeLa cells were tran-
siently co-transfected with Fam96a-V5
and Ciao1-HA or Ciao1-HA alone and the lysates were
immunoprecipitated with monoclonal anti-V5 antibody. Equal
volumes of starting material and immunoprecipitate were
analysed by SDS–PAGE under reducing conditions followed
by Western blotting for HA and V5. Co-immunoprecipitation
of Ciao1-HA with Fam96a-V5 was reproducibly observed
(Fig. 2a). The interaction was dependent on Fam96a, as Ciao1-
HA did not bind to the beads in the absence of Fam96a-V5
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Table 1
Thermodynamic parameters for Fam96a–Ciao1 interactions.
At least three replicate experiments were performed in each case. Values are
expressed as mean  standard error of the mean for three independent
experiments. 1 cal = 4.186 J.
Ciao1 Fam96a H (kcal mol1) G (kcal mol1) Kd (nM) N
Ciao1 Monomer 6.8  0.4 10.7  0.4 18  9.3 1.0
Ciao1 Dimer 6.9  0.7 11.2  0.6 11  4.5 1.0
Figure 2
Fam96a co-immunoprecipitation and topology determination in HeLa cells. (a) HeLa cells were
transiently co-transfected with either Fam96a-V5 and Ciao1-HA or Ciao1-HA alone. SDS–PAGE
and Western blotting of lysates and immunoprecipitates (IP) revealed co-immunoprecipitation of
Ciao1-HA with Fam96a-V5. No immunoprecipitation of Ciao1 was observed in the absence of
Fam96a-V5. LC, IgG light chain. HC, IgG heavy chain. (b) Transfected HeLa cells expressing either
adiponectin-HA, Ciao1-HA or Fam96a-V5 were treated with digitonin to selectively permeabilize
their plasma membranes. While adiponectin-HA was largely protected from protease digestion
following digitonin treatment, Ciao1-HA and Fam96a were clearly susceptible to proteolysis. The
data shown are representative of three or more independent experiments. (c) Transfected HeLa
cells expressing either adiponectin-HA, Ciao1-HA or Fam96a-V5 were subjected to one freeze–
thaw cycle to selectively disrupt their plasma membranes before fixation and immunofluorescent
labelling with or without Triton X-100 detergent permeabilization (Tx100 or No Tx100,
respectively). Adiponectin-HA was brightly labelled after detergent permeabilization but poorly
detectable in the absence of detergent treatment. Both Ciao1 and Fam96a were brightly labelled in
both detergent-treated and untreated cells. Scale bar, 5 mm.
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(Fig. 2a). The interaction of Fam96a with the cytoplasmic/
nuclear protein Ciao1 suggests a cytoplasmic rather than a
lumenal distribution for Fam96a, despite a predicted N-
terminal signal peptide. We therefore proceeded to experi-
mentally determine whether Fam96a is in the cytoplasmic or
the lumenal compartment.
Two independent methods were used to investigate Fam96a
compartmentalization. The first involved selective permeabi-
lization of the plasma membrane using digitonin followed by
trypsin digestion and Western blotting for the C-terminal V5
tag of Fam96a-V5. An endoplasmic reticulum (ER) lumenal
secreted protein, adiponectin-HA, was used as a control to
ensure that lumenal epitopes were protected from protease
treatment, and Ciao1-HA was used as a cytoplasmic positive
control. As shown in Fig. 2(b), Fam96a and Ciao1 were
susceptible to trypsin digestion whilst adiponectin-HA was
protected, indicating that the C-terminal region of Fam96a is
cytoplasmic.
In the second approach, transfected cells expressing either
Fam96a-V5 or adiponectin-HA were subjected to a rapid
freeze–thaw cycle (to selectively
rupture the plasma membrane) before
fixation and immunofluorescent label-
ling with or without prior detergent
permeabilization. Adiponectin-HA was
poorly detectable in the absence of
detergent, as expected for a lumenal
protein, while there was no difference in
the brightness of labelled Fam96a-V5
with or without detergent (Fig. 2c). In
summary, these results showed that the
Ciao-1-interacting region of Fam96a is
cytosolic, not lumenal.
3.4. Fam96a crystal structures reveal
two types of domain-swapped dimers
We solved the crystal structure of
the Fam96a dimer at 1.8 A˚ resolution.
Unexpectedly, the protein formed a
domain-swapped dimer across a crys-
tallographic twofold axis (Fig. 3a,
Table 2). Each subunit has an open
conformation comprising five -helices
and two -strands. The swapped portion
of the structure is located in the middle
of the polypeptide chain, with helix 3
interacting with helices 4 and 5 of an
adjacent symmetry molecule. The
hinge-loop regions that control the
swapping are the proline-rich loop 84-
TPTVPH-89 and the seven-residue loop
121-GTHSTEE-127. Mutation of the
first hinge residues 85-PTVP-88 to
AAAA changed the oligomerization
state of the protein in that only
monomer and oligomer formed
(Fig. 1d). Mutation of 87-VP-88 to AA did not affect the
oligomerization pattern, yielding all three forms observed for
the wild-type protein (Fig. 1d). These results suggested that
the PTVP region may be important for domain-swapped
dimer formation, although only one of the proline residues
may be necessary for this to occur.
The second hinge loop is located C-terminal to the swapped
region and has no associated electron density in the experi-
mental map, indicating that it is highly flexible. Such flexible
loops are common in domain-swapped dimer structures
(Schlunegger et al., 1997; O’Neill et al., 2006). The lack of
density for this region means that there are two possible ways
to connect the polypeptide chain in this crystal form (Fig. 3b).
Automated modelling of the flexible loop using ARP/wARP
selected the mode 1 connection (Fig. 3a, Supplementary Fig.
S4). In the second possible connection mode (mode 2) the
entire C-terminal half of the structure would be domain-
swapped (Fig. 3b). The ARP/wARP approach uses PDB-
derived structural data as driving parameters to select the
more likely mode (Joosten et al., 2008; Langer et al., 2008), but
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Table 2
Data-collection and refinement statistics of Fam96a crystal structures.
Values in parentheses are for the highest resolution shell.
Major dimer, SeMet Minor dimer
Data-collection statistics
Wavelength 0.9184 0.9537
Space group C2221 P21
Resolution range (A˚) 20–1.80 (1.90–1.80) 34–1.80 (1.86–1.80)
Unit-cell parameters (A˚, ) a = 76.4, b = 90.9, c = 34.7,
 =  =  = 90
a = 49.2, b = 52.3, c = 65.9,
 =  = 90,  = 104.6
Total observations 160221 204506
No. of unique reflections 11601 (1659) 30039 (2992)
Completeness (%) 99.9 (100) 99.6 (100)
Rmerge† 0.06 (0.23) 0.08 (0.51)
hI/(I)i 33.9 (15.5) 18.1 (2.8)
Multiplicity 13.8 (14.1) 6.8 (7.2)
Phasing statistics
Overall phasing power 1.11
No. of selenium sites 2 —
FOM (overall/centric/acentric) 0.53/0.32/0.57 —
Refinement statistics
Resolution range (A˚) 19.54–1.80 (1.98–1.80) 34.24–1.80 (1.86–1.80)
No. of reflections used (Rwork/Rfree) 11035/554 28474/1523
Rwork‡/Rfree§ (%) 17.2/20.8 19.6/23.4
No. of atoms
Protein 1139 2353
Water 128 177
Other 2 Se 3 Zn2+, 1 acetate
Wilson B factor (A˚2) 14.0 24.3
Average B factor} (A˚2)
Protein 16.3 36.9
Water 26.4 49.4
Zinc — 38.2
R.m.s.d. isotropic B (main chain/side chain) 1.78/3.54 2.59/5.96
R.m.s.d. ideal values
Bond length (A˚) 0.007 0.006
Bond angles () 1.1 0.95
Ramachandran plot (%)
Favoured 100 100
Allowed 96.3 99.3††
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of the ith observation of reflection
hkl. ‡ Rwork =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where Fobs and Fcalc are the observed and calculated structure-factor
amplitudes for reflection hkl. § Rfree was calculated using 5% of the diffraction data selected randomly and excluded
from refinement. } Calculated using BAVERAGE (Winn et al., 2011). †† Two outliers: Asn73 from each of the two
molecules in the asymmetric unit. This residue is located in a flexible loop.
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we cannot rule out the possibility that Fam96a may form mode
2 or both mode 1 and mode 2 connections.
The structure of Fam96a obtained from a crystal of the
monomeric protein was also solved at 1.8 A˚ resolution.
Surprisingly, the crystal structure of Fam96a revealed a second
type of domain-swapped dimer (Fig. 4a, Table 2), which we
designate the ‘minor dimer’ as opposed to the ‘major dimer’
described above. The two distinct types of domain-swapped
dimer place Fam96a in the quasi-three-dimensional domain-
swapped protein class (Liu & Eisenberg, 2002). In the minor
dimer there are two molecules in the asymmetric unit and
these are very similar to each other (r.m.s.d. of 0.37 A˚ for 130
C atoms). Comparison of the major- and minor-dimer struc-
tures shows they have the same secondary-structure arrange-
ment apart from the two hinge regions. The first hinge, which
is extended in the major dimer (Fig. 5a), forms a tight turn in
the minor dimer connecting 2 and 3 (Fig. 5b). The second
hinge (residues 122-THSTEE-127) is disordered in the major
dimer (Fig. 5c). This hinge defines the swapped portion of the
minor dimer, forming a -strand that interacts with the
equivalent -strand from the second subunit (Figs. 4b and 5d).
Intriguingly, removal of residues 123–157 resulted in Fam96a
that formed larger oligomers only; no dimer or monomer
eluted from SEC (data not shown). This suggests that the
C-terminal region is important for stable monomer and dimer
formation.
Zinc was necessary for crystallization of the minor dimer,
and fluorescence excitation of the minor-dimer crystal gave a
strong peak at 8636 eV consistent with Zn K emission (data
not shown). Addition of zinc to the purified monomer
solution, followed by incubation for a week, resulted in
precipitation of Fam96a; after redissolving in buffer the
protein had formed dimers and oligomers, with little monomer
remaining, as indicated by SEC (Supplementary Fig. S5).
Three zinc ions were observed in the minor-dimer crystal
structure. One zinc ion has a trigonal bipyramidal coordina-
tion, forming equatorial interactions with the sulfurs of two
Cys90 residues and the oxygen of a bound acetate. The two
axial ligands are the hydroxyls of two Ser124 residues in the
dimer, but the zinc cannot coordinate both hydroxyls at once
owing to the geometrical constraints of the site. Difference
electron density suggested disorder of the zinc ion along this
axial direction. All three zinc ions were modelled with
anisotropic B factors.
Interestingly, the zinc ligand Cys90 is located just after the
first hinge loop and Ser124 is part of the second hinge-loop
-strand. The side-chain hydroxyl of a third residue, Thr122,
also part of the second hinge-loop -strand, is 3 A˚ from the
sulfur of Cys90. Thus, the zinc ion coordinates residues from
both hinge loops of both molecules in the domain-swapped
dimer (Fig. 4c), supporting the notion that zinc may act as a
switch between the monomer and minor-dimer forms. The
other two zinc ions have a tetrahedral arrangement: each
coordinates His89 and His123 of one monomer in the asym-
metric unit and Glu150 and GluE153 from a symmetry-related
molecule (Fig. 4d). His89 and His123 are also located on the
two hinge loops. Significantly, His89, Cys90, Thr122 and
His123 are highly conserved within the Fam96 family of
proteins, but Ser124 is not (Supplementary Fig. S6). This
leaves open the question of whether zinc binding and minor-
dimer domain swapping is a common feature of the Fam96a/
Fam96b/MIP18 family proteins or whether it occurs only in
Fam96a proteins.
The structural differences between the two domain-
swapped dimers of Fam96a are summarized in Table 3 and
Fig. 6. The hinge-loop sequences are highly conserved in
Fam96b/MIP18 family proteins (Supplementary Fig. S6),
suggesting that hinge-loop flexibility and major-dimer domain-
swapping is a conserved feature of eukaryotic DUF59-
containing proteins.
4. Discussion
The structures of three bacterial DUF59 family protein
structures have been solved [PDB entries 1uwd (Almeida et
al., 2005), 3lno (Center for Structural Genomics of Infectious
Diseases, unpublished work) and 3cq1 (RIKEN Structural
Genomics/Proteomics Initiative, unpublished work); Supple-
mentary Table S1]. All three are monomers and feature a
putative metal-binding site comprising Asp, Glu, Leu, Thr,
Thr/Ser and Cys residues (Almeida et al., 2005). The equiva-
lent residues in mammalian Fam96a are Asp49, Glu51, Lys52,
Thr86, Val87 and Cys90, i.e. two of the residues are not
conserved in Fam96a. The hydrophobic Leu is proposed to
contribute to a perturbed pKa for the two acidic residues,
which are relatively buried with no basic residues nearby
(Almeida et al., 2005). However, this Leu is replaced by the
basic residue Lys52 in Fam96a and is either a Lys or a His in
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Figure 3
Structure of the Fam96a major dimer. (a) Cartoon representation of the
Fam96a domain-swapped major dimer (mode 1 connection) with the
protomers of the dimer shown in green and blue. (b) Mode 2 connection.
The two possible linkages for hinge 2 (not modelled in the crystal
structure) are indicated by dotted lines.
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other eukaryotic DUF59 proteins (Supplementary Fig. S6),
ruling out this possibility in the eukaryotic proteins. In addi-
tion, the Thr/Ser of the cluster is replaced by Val87 in Fam96a
and is either a Val or an Ile in other eukaryotic DUF59
proteins. Thus, the putative conserved metal-binding site of
bacterial DUF59 proteins is not conserved in Fam96a or
Fam96b.
A model of monomeric Fam96a generated by linking the
two halves of a Fam96a minor dimer at residue His123 was
compared with the structure of Bacillus anthracis DUF59
protein (PDB entry 3lno), which is representative of all three
bacterial DUF59 protein structures (Fig. 7). This comparison
revealed significant differences between the bacterial and
mammalian DUF59 protein structures. Most notably, the
region C-terminal to the second hinge loop is much longer in
Fam96a than in the bacterial proteins (35 compared with 15–
20 residues). Strikingly, the helices formed from these residues
in both the major and minor dimers of Fam96a are located on
the opposite side of the core fold with respect to the same
region of the bacterial DUF59 proteins (Fig. 7). This differ-
ence may be a consequence of the residues following strand
3 and preceding the second hinge loop of Fam96a; the
mammalian proteins all have a Gly (Gly121) at this point,
whereas the bacterial proteins have a Pro-Pro motif
(Supplementary Fig. S6). This region appears to be the busi-
ness end of the molecule in bacterial and mammalian proteins:
domain swapping occurs here, zinc ions are bound at this end
of the molecule and the putative metal-binding site of
bacterial DUF59 proteins is located here. Nevertheless, if the
bacterial and mammalian proteins did evolve from a common
ancestor then their sequences and
structures, and presumably their func-
tions, have diverged remarkably, even
aside from the issue of domain swap-
ping.
Both Y2H data (Rual et al., 2005;
Srinivasan et al., 2007) and co-immuno-
precipitation analysis (Ito et al., 2010)
imply that Fam96b and Ciao1 interact
within cells. We investigated a putative
interaction between Fam96a and Ciao1
directly and found that these two
proteins do indeed interact tightly
in vitro and can be co-immunoprecipi-
tated from cells. Compartmentalization
experiments showed that Fam96a is
cytoplasmic, in agreement with its
interaction with a cytoplasmic protein.
Although biological functions have
been described for Fam96b (Ito et al.,
2010; Yang et al., 2011), these functions
are probably not conserved in Fam96a.
For example, Fam96b mRNA is ubi-
quitously expressed (http://biogps.org),
whilst our data demonstrate that
Fam96a mRNA is expressed at elevated
levels in macrophages. It is therefore
possible that Fam96a has evolved an
immune-related function which is
distinct from that of Fam96b. We are
currently investigating this possibility
by focusing on potential functions for
Fam96a in macrophages.
The finding that Fam96a forms two
distinct types of domain-swapped dimer
was unexpected given that the struc-
tures of three bacterial DUF59 proteins
had been solved showing these to be
monomers. Sequence analysis shows
that the regions involved in domain
swapping are well conserved in the
eukaryotic DUF59 proteins, so that
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Figure 4
Structure of the Fam96a minor dimer. (a) Cartoon representation of the minor dimer (left-hand
protomer shown in the same orientation as in Fig. 3a) and (b) rotated to show the central short
-sheet formed by hinge 2. Bound zinc ions are shown in orange. (c) Enlarged view looking into the
zinc-binding site in the centre of the swapped dimer, showing the protein and acetate ligands. (d)
Enlarged view looking into the zinc-binding site at the edge of the dimer.
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domain swapping is likely to occur in those proteins but is
unlikely in bacterial homologues, in which these regions are
not conserved.
Protein domain swapping has been suggested to have
several possible biological functions. For example, it has been
proposed that the differing structural arrangements available
to a protein through domain swapping (Fig. 6) may enable
globular proteins to form repetitive oligomers that interact
cooperatively with structurally repetitive molecules such as
nucleic acids and oligosaccharides (Wouters et al., 2010). It
may also act as a means of switching a protein between
different states of activity (Wouters et al., 2010). There is no
evidence that Fam96a binds nucleic acids or oligosaccharides
and we found no difference in Ciao1 binding affinity for the
monomeric and major-dimer forms of Fam96a. This suggests
that if domain swapping does switch Fam96a on or off, this
may involve minor-dimer formation or a function additional to
binding Ciao1.
Many domain-swapped dimer proteins, including human
prion protein (Zahn et al., 2000; Knaus et al., 2001; Lee &
Eisenberg, 2003), cystatin C (Janowski et al., 2004; Nilsson et
al., 2004; Janowski et al., 2001) and 2-microglobulin (Eakin
et al., 2004; Liu et al., 2011), are amyloidogenic. A relatively
common feature of amyloid-forming proteins is the formation
of a -strand in the hinge loop (Bennett et al., 2006). Curiously,
a -strand occurs in the second hinge loop of the Fam96a
minor dimer and this structure is stabilized by coordination to
zinc, a metal linked to amyloid-plaque formation in neuro-
degenerative diseases (Zatta et al., 2009). Intriguingly, amyloid-
fibril formation can occur for stefin proteins in the presence of
metal ions, which may reflect an interaction between the
protein and biological surfaces (Zˇerovnik et al., 2011). Redox
processes have also been implicated in amyloid formation and
research papers
646 Chen et al.  Fam96a Acta Cryst. (2012). D68, 637–648
Figure 5
Fam96a hinge-loop analysis. (a) Major dimer and (b) minor dimer hinge
loop 1 and (c) major dimer; (d) minor dimer hinge loop 2 (shown in
orange). The electron density in (a), (b) and (d) corresponds to
simulated-annealing OMIT Fo  Fc maps contoured at 2.5.
Figure 6
Structural arrangements of Fam96a. The model of the monomer (green;
derived from the domain-swapped minor-dimer structure) and crystal
structures of the major dimer (blue) and minor dimer (yellow) highlight
three of the different structural arrangements that are potentially
available to Fam96a.
Table 3
Comparison of the major and minor dimers of Fam96a.
Domain-swapped dimer Major dimer, mode 1 Major dimer, mode 2 Minor dimer
No. of residues per molecule 127 127 127
Residues in hinge loop(s) Thr84–His89 and Thr122–Glu127 Thr84–His89 Thr122–Glu127
No. of residues in swapped domain† 32 68 30
Location of swapped domain Middle, 3 and 3 C-terminal, 3–5 C-terminal, 4 and 5
Total molecular surface per dimer‡ (A˚2) 16434 16434 13349
† Counted from the first residue after the hinge loop. ‡ Total surface area calculated using PISA in the CCP4 program suite (Winn et al., 2011).
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a possible three-way relationship between redox-active
cysteines, domain swapping and amyloid-forming proteins has
been noted (Wouters et al., 2010). There is certainly potential
for the two Cys90 residues of Fam96a to form a disulfide
across the minor dimer in the absence of zinc. This cysteine is
highly conserved across DUF59 proteins (Supplementary Fig.
S6). Moreover, the sulfurs of Cys99 (protomer A) and Cys155
(protomer B, and vice versa) are located near each other
(4 A˚) and could form a disulfide under the right conditions.
The electron-density map shows no evidence of a disulfide
(Supplementary Fig. S7) and the Fam96a SEC oligomerization
pattern did not change when 2 mM fresh DTT was added to
the buffer (not shown). This suggests that disulfide-bond
formation does not occur in Fam96a under the conditions we
used and it is certainly not essential for domain-swapped
dimer formation. Whether the ability of Fam96a to bind zinc
and form disulfides plays a role in amyloid-fibre formation will
be an interesting question for the future.
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